New Chinese herbal drugs (rhizoma et radice) in the eleventh edition of the European pharmacopoeia

Abstract

Fitoterapija predstavlja glavni oblik prevencije i liječenja bolesti u sustavu tradicionalne kineske medicine koja se primjenjuje u Kini već stotinama godina, a u novije vrijeme joj i zapadna medicina pridaje na važnosti. Sa ciljem proširenja znanja u području fitofarmacije, teorijski je istraženo pet biljnih droga dobivenih od korijenja i podanaka kineskih ljekovitih biljaka: Belamcandae chinensis rhizoma, Cyathulae radix, Rehmanniae radix, Sanguisorbae radix i Scrophulariae radix. Pregledom stručne i znanstvene literature, za navedene biljne droge u radu je dan pregled dosadašnjih spoznaja o biljnim izvorima, tradicionalnoj primjeni, fitokemijskom sastavu te pretklinički i klinički dokazanim učincima kao i hrvatski prijevod pripadajućih monografija u aktualnom, 11. izdanju Europske farmakopeje.Phytotherapy is the main form of prevention and treatment of diseases in the system of traditional Chinese medicine, which has been applied in China for hundreds of years, and in recent times Western medicine has also given importance to it. With the aim of expanding the knowledge in the field of phytopharmacy, five herbal drugs obtained from the roots and rhizomes of Chinese medicinal plants were theoretically investigated: Belamcandae chinensis rhizoma, Cyathulae radix, Rehmanniae radix, Sanguisorbae radix and Scrophulariae radix. Through a review of professional and scientific literature, an overview of current knowledge on plant sources, traditional use, phytochemical composition, and preclinical and clinically proven effects, together with the Croatian translation of the corresponding monographs in the actual, 11th edition of the European Pharmacopoeia, is given for the aforementioned herbal drug in this thesis